All News

Retina may provide clues to the severity of multiple sclerosis

Researchers at the Medical University of Vienna are focusing on how the retina can be used as a prognostic marker. Analyses revealed that retinal layer thinning as a result of an MS relapse predicts the severity of future relapses and the likelihood of disability.

Connecticut ophthalmologist pleads guilty in health care fraud scheme

Donald Salzberg, MD, conspired with an alleged accomplice at a medical diagnostic company in a scheme that ran for five years, from 2014 through 2019, according to U.S. attorney’s office in Boston.

Unity Biotechnology announces positive data in phase 2 BEHOLD study of UBX1325 in patients with DME

The study provided evidence of safety, visual acuity improvement and structural stability in a difficult-to-treat patient population.

New York ophthalmologists provide eye care in Haiti

August 12, 2022

Anika Michael, MD, and Benjeil Edghill, MD, both ophthalmology specialists from AdvantageCare Physicians New York City, traveled to Haiti in July on a medical mission of mercy, where they evaluated and treated more than 400 patients and completed approximately 90 surgeries.

Harrington Discovery Institute scholar successfully moves new drug for rare, genetic eye disease into clinical trial

August 11, 2022

With the support of Harrington Discovery Institute at University Hospitals, an ophthalmic therapeutic dubbed KIO-301, initially developed by Richard Kramer, PhD, at the University of California, Berkeley (UCB), has successfully been granted approval to start a Phase 1b, first-in-human clinical trial.

Elkin: Talking about the importance of pediatric eye health and safety

August 10, 2022

Zachary Elkin, MD, MPH, of NYU Langone Eye Center, advises how ophthalmologists and parents should be aware of precautions that should be taken with sports involving small balls and urges the use of protective eyewear.

Henry Ford Health receives $2M philanthropic gift from A.A. Van Elslander Foundation

August 10, 2022

The gift will establish the Philip C. Hessburg, MD – Art Van Elslander Chair in Ophthalmic Research, which will constitute a permanent endowment fund to support the educational research initiatives at Henry Ford Health by the Detroit Institute of Ophthalmology.